,

,

, , -
, 55-60
, 15-20 15-20
- ,
, ,
, , ,
20 40 ,
, ,
4-5 - -
, , , , , , , ,
, , ,
- 10-12 5-7 3-4
, , , ,
/

(), ,

-

- ,

 ,


,
()
,




,





,


-

2 ,









cell ()

Advanced Glycation end products (AGE)

, atherosclerosis , chronic renal
failure,

 Advanced Glycation end products (AGE)

1.

2. ()

3.

4.

5.

..!

 ,






,
- :-2
2
,

2007

100 200

:

()
() 2
28

,

-



-


2 -

10 3

()




,


, , ,
, 2

, ,

5 , 4 , 1


50
21


2
2
1
2 2

3


2
- , ,

2 1




3
,
2 ,
,


1-1
2-4
:

-



3



-

2-3


-

*
1 -
- :

50 1
-
- -

50 4-5

50 10 10
-

1
1 6

3-4 3

3

2 2 -

250

(ASTHMA)
,
2

250 125
2 21

20

- -